Podcasts
Drug Development for Neglected and Orphan Diseases
- SRI Podcast: Jon Mirsalis talks about drug development for neglected and orphan diseases
Jon Mirsalis, Managing Director, SRI Biosciences
October 10, 2010
A large part of SRI’s drug discovery and development process focuses on neglected and orphan diseases. These include rare cancers, neurologic, and infectious diseases that either affect a small part of the general population or primarily found in developing countries. As a nonprofit research institute, SRI has an important role working on cures and treatments for these diseases.
Focus Areas:
Biomedical Sciences + Health
Divisions:
SRI Biosciences 
